123 related articles for article (PubMed ID: 22624806)
21. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity.
Lesmana LA; Lesmana CR; Pakasi LS; Krisnuhoni E
Acta Med Indones; 2012 Jan; 44(1):35-9. PubMed ID: 22451183
[TBL] [Abstract][Full Text] [Related]
22. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis.
Sun HQ; Zhang JY; Zhang H; Zou ZS; Wang FS; Jia JH
J Viral Hepat; 2012 Jun; 19(6):396-403. PubMed ID: 22571901
[TBL] [Abstract][Full Text] [Related]
23. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
Shariff MI; Gomaa AI; Cox IJ; Patel M; Williams HR; Crossey MM; Thillainayagam AV; Thomas HC; Waked I; Khan SA; Taylor-Robinson SD
J Proteome Res; 2011 Apr; 10(4):1828-36. PubMed ID: 21275434
[TBL] [Abstract][Full Text] [Related]
24. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
[TBL] [Abstract][Full Text] [Related]
25. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
26. Serum and urinary metabonomic study of human osteosarcoma.
Zhang Z; Qiu Y; Hua Y; Wang Y; Chen T; Zhao A; Chi Y; Pan L; Hu S; Li J; Yang C; Li G; Sun W; Cai Z; Jia W
J Proteome Res; 2010 Sep; 9(9):4861-8. PubMed ID: 20690664
[TBL] [Abstract][Full Text] [Related]
27. Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients.
Huang HJ; Zhang AY; Cao HC; Lu HF; Wang BH; Xie Q; Xu W; Li LJ
Dig Liver Dis; 2013 Aug; 45(8):677-82. PubMed ID: 23384618
[TBL] [Abstract][Full Text] [Related]
28. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.
Pan WD; Xun RY; Chen YM
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):527-31. PubMed ID: 14607680
[TBL] [Abstract][Full Text] [Related]
29. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Toyo'oka T; Min JZ; Inagaki S; Higashi T; Kagawa Y
J Proteome Res; 2010 Aug; 9(8):3912-22. PubMed ID: 20557141
[TBL] [Abstract][Full Text] [Related]
30. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
[TBL] [Abstract][Full Text] [Related]
31. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
[TBL] [Abstract][Full Text] [Related]
32. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
33. The natural history of chronic hepatitis B: a retrospective study.
Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
35. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B.
Yang J; Zhao X; Liu X; Wang C; Gao P; Wang J; Li L; Gu J; Yang S; Xu G
J Proteome Res; 2006 Mar; 5(3):554-61. PubMed ID: 16512670
[TBL] [Abstract][Full Text] [Related]
36. The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis.
Pirlich M; Selberg O; Böker K; Schwarze M; Müller MJ
Hepatology; 1996 Dec; 24(6):1422-7. PubMed ID: 8938174
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
38. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry.
Dittharot K; Jittorntam P; Wilairat P; Sobhonslidsuk A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):741-748. PubMed ID: 29582629
[TBL] [Abstract][Full Text] [Related]
39. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors.
Minakari M; Molaei M; Shalmani HM; Mohammad Alizadeh AH; Jazi AH; Naderi N; Shavakhi A; Mashayekhi R; Zali MR
Eur J Gastroenterol Hepatol; 2009 May; 21(5):512-6. PubMed ID: 19190500
[TBL] [Abstract][Full Text] [Related]
40. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry.
Yin P; Wan D; Zhao C; Chen J; Zhao X; Wang W; Lu X; Yang S; Gu J; Xu G
Mol Biosyst; 2009 Aug; 5(8):868-76. PubMed ID: 19603122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
